Form 4 Filing for BIOMARIN PHARMACEUTICAL INC

This filing details a transaction by Robert J. Hombach, a director at BIOMARIN PHARMACEUTICAL INC. On June 2, 2026, Mr. Hombach acquired 7,490 shares of Common Stock through a grant of restricted stock units. The transaction code is "A", indicating an acquisition. The price per share is listed as 0.0, with a footnote indicating that this is due to the nature of restricted stock units granted on the specified date, making the price not applicable. Following this transaction, Mr. Hombach now owns 49,360 shares of the company's common stock. This report is filed on Form 4.